Randomized Double Blind Control Trial on Effects of Ranolazine on New Onset Atrial Fibrillation Rates in Post-Operative Cardiac Surgery Patients
Phase of Trial: Phase III
Latest Information Update: 27 Mar 2017
At a glance
- Drugs Ranolazine (Primary)
- Indications Atrial fibrillation
- Focus Therapeutic Use
- 01 Feb 2017 Status changed from completed to discontinued.
- 18 Aug 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Nov 2014 Status changed from recruiting to active, no longer recruiting, as reported by ClinicalTrials.gov.